LM7-23578-32151
4 vaccinations
8 coded responses
42 check-ins
8 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 017 / MA
- Registered
- 2021-08-19
- Relationship
- Child or adolescent in my care
- Guardian
- 9ZS-15026-92222
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-19
Registered in v-safe
-
2021-08-19
Dose 1 — Pfizer-BioNTech
- 2021-08-19
-
2021-08-20
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Cough — Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesFree text: CoughingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-21
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-08-22
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-09-03
-
2021-09-09
Dose 2 — Moderna
- 2021-09-09
-
2021-09-11
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do their normal daily activitiesAdult check-in
- 2021-09-16
- 2021-09-23
- 2021-09-30
- 2021-10-07
-
2021-10-14
Survey response — day 35, dose 2, dependentMedDRA: Oropharyngeal pain, Rhinorrhoea, Unevaluable event — Feeling: FairFree text: Conversation, runny nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-21
- 2021-12-09
-
2022-02-22
Dose 3 — Pfizer-BioNTech
- 2022-02-22
-
2022-02-23
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Balance disorder, Dizziness, Hyperacusis, Irritability, Photophobia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizzy, loss of balance, irritable, sensitive to light and sound,MedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-02-25
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-02-27
- 2022-03-01
- 2022-03-08
- 2022-03-15
-
2022-03-22
Survey response — day 28, dose 3, dependentMedDRA: Rash — Feeling: Good · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: This may or may not need related, but timing of the second dose lines up with a week later onset of a skin rash on the hand which spread to the legs and has persisted despite antibiotic, steroid and antifungal ointments.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-22
Report sent to call center — day 28, dose 3, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-03-29
Survey response — day 35, dose 3, dependentMedDRA: Rash, Skin irritation — Feeling: GoodFree text: Skin rash-irritation, maybe a psoriasis reaction, has not improved despite continued treatment. We have a MD follow up next week. This condition may or may not be related other than it started within 2 weeks of the second dose.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Survey response — day 42, dose 3, dependentMedDRA: Drug ineffective, Psoriasis, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continued rash, now diagnosed as psoriasis, stubbornly not responding well to medication. Trying something new now. Unknown trigger could possibly be an immune response.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Report sent to call center — day 42, dose 3, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-21
Call successfulParticipant prefers to complete VAERS report online
- 2022-05-24
- 2022-08-23
-
2022-09-12
Dose 4 — Pfizer-BioNTech
- 2022-09-12
- 2022-09-16
-
2022-09-17
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Fair · Diarrhea, Abdominal painAdult check-in
- 2022-09-18
- 2022-09-26
-
2022-10-03
Survey response — day 21, dose 4, dependentMedDRA: Abdominal pain upper, Diarrhoea, Flatulence, Unevaluable event — Feeling: GoodFree text: Some days stomach cramps, gassiness, and urgent need to use the bathroom. Occasional diarrhea.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Survey response — day 28, dose 4, dependentMedDRA: Abdominal pain upper, Diarrhoea, Gastrooesophageal reflux disease, Pain — Feeling: GoodFree text: Stomach cramps, pain, diarrhea, reflux. Seem to be subsiding after two plus weeks.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-19 | Pfizer-BioNTech | No |
| 2 | 2021-09-09 | Moderna | No |
| 3 | 2022-02-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Coughing
Release 10 — day 35, dose 2, dependent
Symptoms: Conversation, runny nose, sore throat
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Dizzy, loss of balance, irritable, sensitive to light and sound,
Release 11 — day 28, dose 3, dependent
Symptoms: This may or may not need related, but timing of the second dose lines up with a week later onset of a skin rash on the hand which spread to the legs and has persisted despite antibiotic, steroid and antifungal ointments.
Release 11 — day 35, dose 3, dependent
Symptoms: Skin rash-irritation, maybe a psoriasis reaction, has not improved despite continued treatment. We have a MD follow up next week. This condition may or may not be related other than it started within 2 weeks of the second dose.
Release 11 — day 42, dose 3, dependent
Symptoms: Continued rash, now diagnosed as psoriasis, stubbornly not responding well to medication. Trying something new now. Unknown trigger could possibly be an immune response.
Release 12 — day 21, dose 4, dependent
Symptoms: Some days stomach cramps, gassiness, and urgent need to use the bathroom. Occasional diarrhea.
Release 12 — day 28, dose 4, dependent
Symptoms: Stomach cramps, pain, diarrhea, reflux. Seem to be subsiding after two plus weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Drug ineffective | · | · | ✓ |
| SD | Flatulence | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Psoriasis | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Skin irritation | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Balance disorder | · | · | ✓ |
| SRO | Cough | ✓ | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Hyperacusis | · | · | ✓ |
| SRO | Irritability | · | · | ✓ |
| SRO | Photophobia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release